Search

Boehringer Ingelheim becomes member of IPC

Boehringer Ingelheim becomes member of IPC Boehringer Ingelheim is proud to join the International Poultry Council thus reaffirming its strong long-term commitment to shaping the future of poultry health. The International Poultry Council represents a uni

The Boehringer Ingelheim Veterinary Scholars Program

The aim of the Boehringer Ingelheim Veterinary Scholars Program is to expose students to biomedical research

Transboundary animal diseases and veterinary preparedness

What are transboundary animal diseases (TADs)? Bluetongue virus, foot-and-mouth disease and avian influenza are pathogens belonging to this group.

Early Access Treatments & Compassionate Use Programs

Explore how we facilitate patient access to investigational and/or unlicensed medicines through our individual requests and Compassionate Use programs

Early careers

At Boehringer Ingelheim, we know how important it is to lay the right foundations in your career and build on them with care and support.

Targeting HER2 in cancer: The story of zongertinib

We discovered zongertinib, an HER2 tyrosine kinase inhibitor, being developed as a potential oral treatment for people with HER2-mutated NSCLC

Targeting Tumor Stroma

Boehringer Ingelheim’s research approach in stromal biology may lead to new medicines that will change the face of cancer and give new hope to patients

Aservo EquiHaler wins Red Dot 2020 for design quality

Aservo EquiHaler wins a prestigious Red Dot Award 2020 for outstanding design quality

Refolding of Inclusion Bodies

Algorithms to battle heartworm disease

Partnership with the University of Melbourne uses AI to develop new veterinary solutions for pets

Boehringer Ingelheim invests in precision cancer treatments

Boehringer Ingelheim Venture Fund invests in Synthetica as part of its commitment to advancing innovative, next-generation cancer therapies

Trailr2-cdh17-antibody-phase1-trial

Boehringer Ingelheim advances a bi-specific therapeutic antibody to first-in-human clinical trial for patients with advanced gastrointestinal cancers

Collaboration-with-OxfordBioTherapeutics

Boehringer Ingelheim collaborates with Oxford BioTherapeutics to discover tumor targets to deliver first-in-class treatments for cancer patients.

Collaboration with Mary Tyler Moore Vision Initiative

Boehringer Ingelheim joins forces with Mary Tyler Moore Vision Initiative to combat vision loss from diabetes

FOYA_Shanghai

Boehringer Ingelheim’s commercial manufacturing facility in Shanghai has been awarded as “Facility of the Year”

Animal Welfare through environmental sustainability

Producing honey and contributing to environmental sustainability during your work hours.

Redefining mental health to enable people to thrive

At Boehringer Ingelheim, we aim to develop targeted treatment approaches that address specific symptoms in people living with mental illness.

Boehringer acquires T3 Pharma

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma

Joint venture to fight Antimicrobial Resistance

Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

SPEVIGO (spesolimab) wins 2023 Prix Galien USA Award

SPEVIGO® (spesolimab) wins 2023 Prix Galien USA Best Orphan/Rare Diseases Solution Award

Do you take periodontal disease in dogs seriously? We do!

Periodontal Disease? Brushing teeth is vital to prevent doggy breath, but not enough to ensure animal health and well-being

inauguration_biopharmaceutical_production_facility_vienna

The state-of-the-art biopharmaceutical production facility in Vienna is the single largest investment in the company's history.

Partnering with Lifebit to detect global disease outbreaks

Boehringer Ingelheim partners with Lifebit to detect global infectious disease outbreaks

bix_facilitates_global_partnerships

BI X focuses on partnerships to speed up the development of digital healthcare solutions

digital_leader_award_2020

Boehringer Ingelheim wins first place in the "STRATEGY" category of the Digital Leader Award

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers